Back to search

Article

Screening the human druggable genome identifies ABHD17B as an anti-fibrotic target in hepatic stellate cells

2023-08-07

Abstract excerpt

Hepatic stellate cells (HSCs) are activated with chronic liver injury and transdifferentiate into myofibroblasts, which produce excessive extracellular matrices that form the fibrotic scar. While the progression of fibrosis is understood to be the cause of end-stage liver disease, there are no approved therapies directed at interfering with the activity of HSC myofibroblasts. We performed a high-throughput small i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d76ddcda-aac2-5a27-95cf-a812858baf1d
DOI
10.1101/2023.08.07.551744
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Screening the human druggable genome identifies ABHD17B as an anti-fibrotic target in hepatic stellate cellsDOI 10.1101/2023.08.07.551744
Select a neighboring publication to make it the new centre.